Literature DB >> 18723384

Pallidonigral TDP-43 pathology in Perry syndrome.

Christian Wider1, Dennis W Dickson, A Jon Stoessl, Yoshio Tsuboi, Françoise Chapon, Ludwig Gutmann, Bernard Lechevalier, Donald B Calne, David A Personett, Mary Hulihan, Jennifer Kachergus, Rosa Rademakers, Matthew C Baker, Linda L Grantier, O K Sujith, Laura Brown, Susan Calne, Matthew J Farrer, Zbigniew K Wszolek.   

Abstract

OBJECTIVE: Autosomal dominant parkinsonism, hypoventilation, depression and severe weight loss (Perry syndrome) is an early-onset rapidly progressive disease. At autopsy, previous studies have found severe neuronal loss in the substantia nigra without Lewy bodies. Transactive response DNA-binding protein of 43 kDa (TDP-43) has recently been identified as a major ubiquitinated constituent of neuronal and glial inclusions in frontotemporal lobar degeneration with ubiquitin-positive inclusions and in amyotrophic lateral sclerosis. This study reports clinical, genetic and neuropathologic investigations of Perry syndrome.
METHODS: Clinical data and autopsy brain tissue samples were collected from eight patients from four genealogically unrelated kindreds with Perry syndrome. Brain tissue was studied with immunohistochemistry and biochemistry for TDP-43. Patients were screened for mutations in the progranulin (GRN) and TDP-43 (TARDBP) genes.
RESULTS: The mean age at onset was 47 years (range 40-56), and the mean age at death was 52 years (range 44-64). In all patients, we identified TDP-43-positive neuronal inclusions, dystrophic neurites and axonal spheroids in a predominantly pallidonigral distribution, and we demonstrated changes in solubility and electrophoretic mobility of TDP-43 in brain tissue. The inclusions were highly pleomorphic and predominated in the extrapyramidal system, sparing the cortex, hippocampus and motor neurons. There were no mutations in GRN or TARDBP.
INTERPRETATION: Perry syndrome displays unique TDP-43 pathology that is selective for the extrapyramidal system and spares the neocortex and motor neurons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723384      PMCID: PMC2693935          DOI: 10.1016/j.parkreldis.2008.07.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  38 in total

1.  Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome: clinical, biochemical, and neuropathologic studies of 2 new cases.

Authors:  T L Perry; J M Wright; K Berry; S Hansen; T L Perry
Journal:  Neurology       Date:  1990-12       Impact factor: 9.910

2.  Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.

Authors:  Keith A Josephs; Zeshan Ahmed; Omi Katsuse; Joseph F Parisi; Bradley F Boeve; David S Knopman; Ronald C Petersen; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Ryan J Uitti; Rosa Rademakers; Jennifer Adamson; Matthew Baker; Michael L Hutton; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2007-02       Impact factor: 3.685

3.  TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.

Authors:  Manuela Neumann; Ian R Mackenzie; Nigel J Cairns; Philip J Boyer; William R Markesbery; Charles D Smith; J Paul Taylor; Hans A Kretzschmar; Virginia E Kimonis; Mark S Forman
Journal:  J Neuropathol Exp Neurol       Date:  2007-02       Impact factor: 3.685

4.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

5.  Familial parkinsonism, apathy, weight loss, and central hypoventilation: successful long-term management.

Authors:  E P Roy; J E Riggs; J D Martin; R A Ringel; L Gutmann
Journal:  Neurology       Date:  1988-04       Impact factor: 9.910

6.  Japanese family with parkinsonism, depression, weight loss, and central hypoventilation.

Authors:  Y Tsuboi; Z K Wszolek; T Kusuhara; K Doh-ura; T Yamada
Journal:  Neurology       Date:  2002-04-09       Impact factor: 9.910

7.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

Review 8.  [Familial parkinsonian syndrome with athymhormia and hypoventilation].

Authors:  B Lechevalier; C Schupp; C Fallet-Bianco; F Viader; F Eustache; F Chapon; P Morin
Journal:  Rev Neurol (Paris)       Date:  1992       Impact factor: 2.607

9.  Familial fatal Parkinsonism with alveolar hypoventilation and mental depression.

Authors:  A Purdy; A Hahn; H J Barnett; P Bratty; D Ahmad; K G Lloyd; E G McGeer; T L Perry
Journal:  Ann Neurol       Date:  1979-12       Impact factor: 10.422

10.  Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype.

Authors:  Ian R A Mackenzie; Atik Baborie; Stuart Pickering-Brown; Daniel Du Plessis; Evelyn Jaros; Robert H Perry; David Neary; Julie S Snowden; David M A Mann
Journal:  Acta Neuropathol       Date:  2006-09-26       Impact factor: 17.088

View more
  41 in total

Review 1.  TAR DNA-binding protein 43 in neurodegenerative disease.

Authors:  Alice S Chen-Plotkin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurol       Date:  2010-03-16       Impact factor: 42.937

2.  Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed.

Authors:  David B Wang; Robert D Dayton; Phillip P Henning; Cooper D Cain; Li Ru Zhao; Lisa M Schrott; Elysse A Orchard; David S Knight; Ronald L Klein
Journal:  Mol Ther       Date:  2010-09-28       Impact factor: 11.454

Review 3.  Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration.

Authors:  T F Gendron; K A Josephs; L Petrucelli
Journal:  Neuropathol Appl Neurobiol       Date:  2010-02-19       Impact factor: 8.090

4.  In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers.

Authors:  Andre C Felicio; Katherine Dinelle; Pankaj A Agarwal; Jessamyn McKenzie; Nicole Heffernan; Jeremy D Road; Silke Appel-Cresswell; Zbigniew K Wszolek; Matthew J Farrer; Michael Schulzer; Vesna Sossi; A Jon Stoessl
Journal:  Mov Disord       Date:  2014-05-05       Impact factor: 10.338

Review 5.  DCTN1-related neurodegeneration: Perry syndrome and beyond.

Authors:  Takuya Konno; Owen A Ross; Hélio A G Teive; Jarosław Sławek; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2017-06-12       Impact factor: 4.891

6.  TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease.

Authors:  Eileen H Bigio; Manjari Mishra; Kimmo J Hatanpaa; Charles L White; Nancy Johnson; Alfred Rademaker; Bing Bing Weitner; Han-Xiang Deng; Steven D Dubner; Sandra Weintraub; Marsel Mesulam
Journal:  Acta Neuropathol       Date:  2010-04-02       Impact factor: 17.088

7.  Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy.

Authors:  Shunsuke Koga; Monica Sanchez-Contreras; Keith A Josephs; Ryan J Uitti; Neill Graff-Radford; Jay A van Gerpen; William P Cheshire; Zbigniew K Wszolek; Rosa Rademakers; Dennis W Dickson
Journal:  Mov Disord       Date:  2016-12-23       Impact factor: 10.338

8.  Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy.

Authors:  Takayasu Mishima; Shunsuke Koga; Wen-Lang Lin; Koji Kasanuki; Monica Castanedes-Casey; Zbigniew K Wszolek; Shin J Oh; Yoshio Tsuboi; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2017-08-01       Impact factor: 3.685

Review 9.  Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.

Authors:  Felix Geser; Maria Martinez-Lage; Linda K Kwong; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurol       Date:  2009-03-07       Impact factor: 4.849

10.  TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy.

Authors:  Michael A Gitcho; Eileen H Bigio; Manjari Mishra; Nancy Johnson; Sandra Weintraub; Marsel Mesulam; Rosa Rademakers; Sumi Chakraverty; Carlos Cruchaga; John C Morris; Alison M Goate; Nigel J Cairns
Journal:  Acta Neuropathol       Date:  2009-07-18       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.